Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dmytro Kyriienko"'
Autor:
Maryana Savytska, Dmytro Kyriienko, Ganna Zaychenko, Danylo Ostapchenko, Tetyana Falalyeyeva, Nazarii Kobyliak
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionThere is growing evidence from animal and clinical studies suggesting probiotics can positively affect type 2 diabetes (T2D). In a previous randomized clinical study, we found that administering a live multistrain probiotic and absorbent
Externí odkaz:
https://doaj.org/article/af93333864b84656930c97e2a091615d
Autor:
Dmytro Kyriienko, Larysa Shuliarenko, Iuliia Komisarenko, Nazarii Kobyliak, Liudmyla Kononenko, Ludovico Abenavoli, Mahmoud Aludwan
Publikováno v:
Clinical Diabetology. 9:313-320
Background. Recently, vitamin D3 deficiency is considered one of the factors associated with the development of non-alcoholic fatty liver disease (NAFLD). The aim was to evaluate steatosis indices and metabolic parameters in NAFLD depending on vitami
Autor:
Nazarii Kobyliak, Liudmila Ostapchenko, Dmytro Kyriienko, Tetyana Falalyeyeva, Olena Tsyryuk, Tetyana Beregova, Majid Eslami
Publikováno v:
J Diabetes Metab Disord
BACKGROUND AND AIMS: сomparative animal study of effectiveness of intermittent administration of lyophilized single-, three- and alive multistrain probiotic in short courses on insulin resistance (IR) in rats with experimental obesity. METHODS: 70 r
Autor:
Ludovico Abenavoli, Olena Tsyryuk, Liudmyla Kononenko, Galyna Mykhalchyshyn, Iuliia Komisarenko, Nazarii Kobyliak, Dmytro Kyriienko, Tetyana Falalyeyeva
Publikováno v:
Clinical Diabetology. 8:205-214
Introduction. In double-blind single center randomized clinical trial (RCT), the efficacy of alive probiotics supplementation with smectite gel vs. placebo in type 2 diabetes patient with non-alcoholic fatty liver disease (NAFLD) detected on ultras
Publikováno v:
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 13:228-234
Wound healing in diabetes is frequently impaired and its treatment remains a challenge. The ability of topical application of cerium (Ce) dioxide nanoparticles (CNPs) to accelerate wound healing in an animal model provides a rationale to develop this
Autor:
Nazarii Kobyliak, Mahmoud Aludwan, Rinaldo Pellicano, Dmytro Kyriienko, Ludovico Abenavoli, Sharmila Fagoonee, Iuliia Komisarenko
Publikováno v:
Minerva endocrinologica (Testo stamp.) 45 (2020): 172–180. doi:10.23736/S0391-1977.20.03161-2
info:cnr-pdr/source/autori:Aludwan, Mahmoud; Kobyliak, Nazarii; Abenavoli, Ludovico; Kyriienko, Dmytro; Fagoonee, Sharmila; Pellicano, Rinaldo; Komisarenko, Iuliia/titolo:Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes/doi:10.23736%2FS0391-1977.20.03161-2/rivista:Minerva endocrinologica (Testo stamp.)/anno:2020/pagina_da:172/pagina_a:180/intervallo_pagine:172–180/volume:45
info:cnr-pdr/source/autori:Aludwan, Mahmoud; Kobyliak, Nazarii; Abenavoli, Ludovico; Kyriienko, Dmytro; Fagoonee, Sharmila; Pellicano, Rinaldo; Komisarenko, Iuliia/titolo:Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes/doi:10.23736%2FS0391-1977.20.03161-2/rivista:Minerva endocrinologica (Testo stamp.)/anno:2020/pagina_da:172/pagina_a:180/intervallo_pagine:172–180/volume:45
Background: Vitamin D3 (vit. D3) deficiency is considered as one of the main factors involved in the development of type 2 diabetes (T2D). We assessed insulin resistance (IR), ?-cell functional activity and metabolic profile according to 25(OH) vit.
Publikováno v:
Endocrine Abstracts.
Autor:
Dmytro Kyriienko, Olexiy Savchuk, Galyna Mykhalchyshyn, Iuliia Komisarenko, Ostapchenko Li, Tetyana Falalyeyeva, Nazarii Kobyliak
Publikováno v:
Endocrine Abstracts.
Autor:
Nazarii Kobyliak, Tetyana Falalyeyeva, Oleksandr Kovalchuk, Iuliia Komisarenko, Dmytro Kyriienko, Ludovico Abenavoli
Publikováno v:
Reviews on recent clinical trials. 16(1)
Background: Numerous non-drug therapies have emerged in recent years for the prevention and improvement of type 2 diabetes (T2D). However, therapies based on dietary modification and/or microbiota may replace a large part of drug therapies in the com
Autor:
Luigi Boccuto, Nazarii Kobyliak, Ludovico Abenavoli, Galyna Mykhalchyshyn, Oleg Dynnyk, Dmytro Kyriienko, Liudmyla Kononenko
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 27:41-49
Background: Probiotics have a beneficial effect on nonalcoholic fatty liver disease (NAFLD) in animal models. Randomized placebo-controlled trials (RCTs) in NAFLD are still lacking in humans despite a large number of data from animal research.Aim: We